Oncothyreon, Inc. (ONTY) Posts Q2 Loss of 91c/Share
Tweet
Share
E-mailGet Alerts ONTY Hot Sheet
Join SI Premium – FREE
Oncothyreon, Inc. (NASDAQ: ONTY) reported Q2 loss of ($0.91), $0.75 worse than the analyst estimate of ($0.16).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
